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Abstract
Background: Despite clinical practice guidelines recommending the routine provision of nicotine dependence
treatment to smokers in inpatient psychiatric facilities, the prevalence of such treatment provision is low. The aim of
this study was to examine the effectiveness of a clinical practice change intervention in increasing clinician
recorded provision of nicotine dependence treatment to patients in inpatient psychiatric facilities.
Methods: We undertook an interrupted time series analysis of nicotine dependence treatment provision before,
during and after a clinical practice change intervention to increase clinician recorded provision of nicotine
dependence treatment for all hospital discharges (aged >18 years, N = 4175) over a 19 month period in two
inpatient adult psychiatric facilities in New South Wales, Australia. The clinical practice change intervention
comprised six key strategies: leadership and consensus, enabling systems and procedures, training and education,
information and resources, audit and feedback and an on-site practice change support officer. Systematic medical
record audit and segmented logistic regression was used to determine differences in proportions for each nicotine
dependence treatment outcome measure between the ‘pre’, ‘during’ and ‘post-intervention’ periods.
Results: The prevalence of all five outcome measures increased significantly between the pre and post-intervention
periods, including clinician recorded: assessment of patient smoking status (36.43 to 51.95%; adjusted odds ratio
[AOR] = 2.39, 99% Confidence Interval [CI]: 1.23 to 4.66); assessment of patient nicotine dependence status (4.74 to
11.04%; AOR = 109.67, 99% CI: 35.35 to 340.22); provision of brief advice to quit (0.85 to 8.81%; AOR = 97.43, 99% CI:
31.03 to 306.30); provision of nicotine replacement therapy (8.06 to 26.25%; AOR = 19.59, 99% CI: 8.17 to 46.94); and
provision of nicotine dependence treatment on discharge (8.82 to 13.45%, AOR = 12.36; 99% CI: 6.08 to 25.14).
Conclusions: This is the first study to provide evidence that a clinical practice change intervention may increase
clinician recorded provision of nicotine dependence treatment in inpatient psychiatric settings. The intervention
offers a mechanism for psychiatric facilities to increase the provision of nicotine dependence treatment in
accordance with clinical guidelines.
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Background
Smoking remains a leading global cause of death and
disability [1]. While smoking rates and the corre-
sponding burden of premature death and disability
have declined in the general population, this has not
been observed among persons with a mental disorder
[2, 3]. As a consequence, smoking rates are two to
three times higher [4], nicotine dependence is more
severe [4], quit attempts are less likely to be success-
ful [5, 6], and rates of smoking related morbidity and
mortality are substantially higher among persons with
such a disorder [7, 8]. Smoking prevalence and its’
associated burden appear to increase with greater
severity of mental illness [9], with higher prevalence
among psychiatric inpatients [10]. Reduction of the
prevalence of smoking in this population is both a
recognised public health priority and a clinical prior-
ity for mental health services [11, 12].
Despite clinical practice guidelines [13, 14] recom-
mending the provision of nicotine dependence treatment
to patients in mental health treatment settings in devel-
oped nations such as the United States, United Kingdom
and Australia [13–15], the provision of such treatment
in psychiatric facilities has been suboptimal, with assess-
ment of nicotine dependence and provision of nicotine
replacement therapy (NRT) in inpatient psychiatric
facilities occurring rarely (0%–0.5%) [16, 17]. Reported
barriers to the provision of such treatment include lack
of time and clinician skill and experience, and lack of or-
ganisational support, even when comprehensive nicotine
dependence treatment guidelines are in place [18].
Systematic review evidence supports the effectiveness
of a number of clinical practice change strategies for im-
proving health-related practices across a range of clinical
settings, including: engaging local opinion leaders [19],
audit and feedback [20], reminders [21], clinical decision
support systems [22], training and education [23], the
development and dissemination of clinical practice
guidelines [24], and dissemination of educational
materials [22]. Such strategies found to be effective in
increasing the implementation of nicotine dependence
treatment specifically, include staff training and educa-
tion [25], and use of electronic health records [26]. A
systematic review and meta-analysis of controlled studies
demonstrated that such clinical practice change strat-
egies can increase staff provision of assistance to quit to
patients in hospital settings (pooled risk difference: 16.6;
95% confidence interval: 4.9 to 28.3) but no effect was
found for staff assessment of smoking status, advice to
quit, or the provision or discussion of NRT [27]. The re-
view identified no studies that reported the effectiveness
of clinical practice change interventions in increasing
the implementation of nicotine dependence treatment in
inpatient psychiatric facilities.
To address this evidence gap, a study was undertaken to
assess the effectiveness of a multi-modal clinical practice-
change intervention in increasing clinician recorded
provision of five recommended elements of nicotine de-
pendence treatment: 1) assessment of smoking status; 2)
assessment of nicotine dependence; 3) provision of brief
advice to quit; 4) provision of NRT; and 5) provision of
nicotine dependence treatment at discharge to patients
admitted to inpatient psychiatric facilities.
Methods
Study design
An interrupted time series study was undertaken. A clin-
ical practice change intervention was implemented for
nine months, with outcome data collected for three pe-
riods over 19 months: ‘pre-intervention’ (five months
from 1st June to 31st October 2009), ‘intervention period’
(nine months from 1st November 2009 to 31st July
2010), and ‘post-intervention’ (five months from 1st
August to 31st December 2010).
Setting
The study was undertaken concurrently in a conveni-
ence sample of two of four general locked adult in-
patient psychiatric facilities in one health district in New
South Wales, Australia. One facility (100 beds) consisted
of a discrete psychiatric facility catering for approxi-
mately 2000 patient discharges per annum across five
units: an emergency/intensive care unit, two general
acute units, a dual diagnosis unit, and an older persons
unit. The second psychiatric facility (125 beds) catered
for approximately 750 patient discharges per annum
from a single general acute psychiatric care unit. Both
facilities introduced a smoke-free policy in all buildings
and grounds three years prior to the study.
Participants
The study participants consisted of all adult (>18 years) pa-
tient discharges, including repeat discharges for individual
patients, and for both voluntary and involuntary patients.
Nicotine dependence treatment
All clinical staff (approximately 170), including registered
nurses, nurse managers, allied health professionals, and
medical/psychiatric staff received the intervention. Based
on both local and international clinical guidelines [13, 14],
clinical staff were asked to provide the following five ele-
ments of nicotine dependence treatment: 1) assessment of
smoking status of all patients on admission; 2) assessment
of nicotine dependence; 3) provision of quit advice; 4)
provision of NRT (including nicotine patch, lozenge, gum,
or inhaler); and 5) provision of any component of nicotine
dependence treatment at discharge (including any of brief
advice to quit, offer of referral to the Quitline telephone
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support service, and provision of NRT at discharge). Other
forms of pharmacotherapies for nicotine dependence
treatment, including varenicline and bupropion were not
available to patients through the hospital pharmacy, and
nicotine oral and nasal sprays were not approved for use
in Australia at the time of the study.
Clinical practice change intervention
The following strategies, informed by clinical practice
change evidence [19–24] and evidence of strategies to im-
prove nicotine dependence treatment in healthcare settings
[25–27] were implemented to support the routine provision
of nicotine dependence treatment by clinical staff:
 Leadership and consensus
a. Consultation with senior medical, nursing and
facility management staff
b. Unit level meetings with managers, and clinical
leaders and staff using the principles of
motivational interviewing [28];
c. Meetings with consumer advocates, and;
d. Appointment of local (minimum of 1 per unit)
clinical champions.
 Enabling systems and procedures
a. Distribution of state nicotine dependence treatment
guidelines, the NSW Health Guide for the
Management of Nicotine Dependent Inpatients [14]
(see Additional file 1) to clinical staff, and;
b. Modification of existing admission forms to
prompt recording of smoking treatment.
 Training and education
o Face-to-face staff group training sessions (n = 30) to
increase awareness, agreement and adoption of
nicotine dependence treatment guidelines;
o Problem solving with local champions and
clinician groups on ‘as needs’ basis (n = 33), and;
o Information sessions for patients and carer
groups.
 Practice change information and resources
o All clinical staff and managers were provided:
a treatment flowchart (see Additional file 1); a
guide for providing and recording treatment;
tailored information regarding smoking and
mental health and use of NRT; educational
resources for patients; and information
regarding support for smoking abstinence or
cessation by staff.
 Audit and feedback
o Audit and feedback of unit medical records
regarding prevalence of nicotine dependence
treatment (n = 14 face to face information
sessions held in total with clinical staff across
the six units to provide tailored feedback on the
performance of their unit).
 Practice change Support
A practice change support officer (0.5 FTE) was avail-
able to support delivery of the above strategies.
Data collection procedures
All components of the medical record for each patient dis-
charged during the study period were audited post-
discharge by trained auditors employed by the research
team [16, 29]. Auditors were non-clinical health service
staff based in the hospital medical records department,
were not specifically linked to or affiliated with the psychi-
atric facilities and were independent of the study team.
Auditors were aware that the audit pertained to tobacco
use, but were not privy to the intervention activities.
Measures
a) Patient characteristics
The following patient characteristics were obtained
from the medical record: gender, age (determined by
date of birth), admission and discharge dates, previous
admissions (yes, no), number of discharges during study
period), treating unit at discharge, Aboriginal or Torres
Strait Islander status (yes, no, unknown), English speak-
ing (yes, no, unknown). Patient diagnosis was classified
via ICD-10 codes [30].
b) Nicotine dependence treatment
Based on the NSW Health Guide for the Management of
Nicotine Dependent Inpatients [14], see Additional file 1)
the recorded provision of five elements of nicotine
dependence treatment was audited:
1. assessment of smoking status (yes, no);
2. assessment of nicotine dependence (yes, no);
3. provision of brief advice to quit (yes, no);
4. prescription of any form of NRT (including nicotine
patch, lozenge, gum, or inhaler) (yes, no), and;
5. provision of nicotine dependence treatment on
discharge record (any of: provision of written
information/brief advice to quit, offer of referral
to Quitline, and provision of NRT post discharge)
(yes, no).
Analysis
Analyses were conducted using SAS version 9.4 software
[31]. Admission and discharge dates were used to calculate
length of stay. Diagnoses were collapsed into eight most
prevalent categories: schizophrenia/psychosis; affective dis-
orders; adjustment/anxiety disorders; substance use disor-
ders; borderline personality disorder; bipolar disorder;
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dementias, and other mental disorder. For smoking status
assessment and provision of brief advice outcomes, audit
data from multiple medical record locations were collapsed
to form a single measure (recorded/not recorded anywhere).
Descriptive statistics were used to summarise patient
characteristics, and prevalence of each of the nicotine
dependence treatment measures at each of three time
periods (pre-intervention, intervention and post-
intervention). Chi-square analyses were undertaken to
assess differences in patient socio-demographic and
clinical characteristics between patients with one or
more admission, and between study periods.
Similar to other studies of nicotine dependence treat-
ment in hospital settings based on medical record audit
[32, 33], each outcome measure is reported as a propor-
tion of the total patient sample (both smokers and non-
smokers). Smoking prevalence was assumed to be
constant during the study period, based on previous re-
search conducted in this facility [16, 34], and elsewhere
[2]. The proportions for each outcome were plotted for
each fortnight in the study period [35]. Segmented logis-
tic regression analysis of interrupted time series data
was used to determine differences in outcome propor-
tions between the pre- and during, during and post-,
and pre to post-intervention periods, to plot outcome
proportions across the 19-month study period [36].
Month was the unit of time chosen to generate the
slopes in the logistic regression analyses, and as such
there were five time points (i.e. months) in the pre-
intervention period (1st June to 31st October 2009), nine
time points in the ‘intervention period’ (1st November
2009 to 31st July 2010), and five time points in the ‘post-
intervention’ period (1st August to 31st December 2010).
The models adjusted for differences in patient socio-
demographic and clinical characteristics (including dis-
charging unit) between study periods. All discharges
were treated independently in the analyses. All statistical
tests were two-tailed, and the threshold for statistical
significance was p < 0.01. We used the conservative 1%
threshold for statistical significance (and corresponding
99% Confidence Intervals [CIs]) in an attempt to correct
for an increased overall type I error rate from the
multiple tests (and intervals) that were conducted.
Results
Patient characteristics
There were 4,175 discharges (1054 pre-intervention;
2054 during intervention and 1078 post-intervention)
during the 19 month study period for 2,898 individual
patients. Nearly one third of total discharges (n = 1277,
30.6%) were for patients readmitted to the facilities
during the study period. There were no differences in
socio-demographic or clinical characteristics between
patients who had one or multiple admissions.
Across the total study period, patients were mostly male
(55%), had an average age of 39.2 years (SD = 15.3) and an
average length of stay of 17.0 days (SD = 33.4). The most
prevalent primary diagnoses on admission were schizo-
phrenia and related psychosis (25%), adjustment disorders
(18%) and unipolar affective disorders (17%). Primary
diagnosis on admission, and discharging unit were identi-
fied to vary significantly between study periods (p < .0001),
and these variable were added as confounding variables to
the segmented logistic regression models (Table 1).
Nicotine dependence treatment
The following results were robust to adjustment for po-
tentially confounding variables, and did not differ be-
tween patients who had one or multiple admissions.
Adjusted results are shown in text, and unadjusted re-
sults are provided in Table 1 in the Additional file 1.
1. Assessment of smoking status
The prevalence of recorded assessment of patient
smoking status increased significantly between each of
the study periods, with an overall significant increase
from pre- to post-intervention (15.52% absolute increase,
99% Confidence Interval [CI]: 10.04 to 20.99; Table 2).
As shown in Fig. 1 and Table 3, overall, the odds of
smoking status being assessed increased significantly
from pre-intervention to the end of the post-
intervention period (adjusted odds ratio [AOR] = 2.39,
99% CI: 1.23 to 4.66), driven by increases from the pre-
to intervention period (Fig. 1, Table 3).
2. Assessment of nicotine dependence
The prevalence of recorded assessment of nicotine de-
pendence was stable in the pre-intervention phase, and in-
creased significantly from intervention to post-
intervention, with an overall significant increase from pre-
to post-intervention (6.30% absolute increase, 99% CI:
3.31 to 9.28; Table 2). As shown in Fig. 1 and Table 3,
overall the odds of a nicotine dependence assessment be-
ing recorded increased significantly from pre-intervention
to the end of the post-intervention period (AOR = 109.67,
99% CI 35.35, 340.22; Table 3), with increases in odds oc-
curring between each time period (Fig. 1, Table 3).
3. Provision of brief advice to quit
The prevalence of recorded brief advice to quit in-
creased significantly between each of the study periods,
with an overall significant increase from pre-to post
intervention (7.96% absolute increase, 99% CI: 5.62 to
10.30; Table 2). As shown in Fig. 1 and Table 3, the odds
of recorded provision of brief advice to quit increased
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significantly from pre to post-intervention (AOR = 97.43,
99% CI 31.03, 306.30), with increases in odds occurring
between each time period (Table 3).
4. Prescription of NRT
The prevalence of recorded prescription of NRT in-
creased significantly between each of the study periods,
with an overall significant increase from pre-to post-
intervention (18.19% absolute increase, 99% CI: 14.12 to
22.26; Table 2). As shown in Fig. 1 and Table 3, the odds
of recorded prescription of NRT increased significantly
from pre- to post-intervention (AOR = 19.59, 99% CI:
8.17 to 46.94), with this being driven by increases from
the pre- to intervention period (Table 3).
5. Provision of nicotine dependence treatment at
discharge
Table 1 Socio-demographic and clinical characteristics of the patient sample at the three audit periods, pre- (n = 1054),












Male 573 (54%) 1110 (54%) 597 (55%) 2280(55%)
First admission to facility? 0.1123
Yes 410 (39%) 841 (41%) 402 (38%) 1653(40%)
Planned discharge? 0.3193
Yes 1019 (99%) 2004 (99%) 1064 (99%) 4087(99%)
Discharging unit <.0001
Emergency and intensive care 93 (9%) 364 (18%) 241 (23%) 698(17%)
General acute unit 1 235 (23%) 334 (16%) 152 (14%) 721(17%)
General acute unit 2 226 (22%) 465 (23%) 164 (15%) 855(20%)
Comorbid mental health and substance use unit 209 (20%) 341 (17%) 207 (19%) 757(18%)
Rural acute unit 223 (21%) 443 (22%) 243 (23%) 909(22%)
Older persons unit 52 (5%) 89 (4%) 66 (6%) 207(5%)
Identified as Aboriginal or Torres Strait Islander? 0.0325
Yes 83 (7.9%) 199 (9.8%) 121 (11%) 403(10%)
No or unknown 968 (92%) 1840 (90%) 955 (89%) 3763(90%)
English speaking 0.0232
Yes 1019 (97%) 1994 (98%) 1062 (99%) 4075(98%)
No or unknown 32 (3.0%) 46 (2.3%) 14 (1.3%)
Primary diagnosis on admission <0.0001
Schizophrenia and related psychosis 262 (25%) 524 (26%) 251 (23%) 1037(25%)
Unipolar affective disorder 204 (19%) 320 (16%) 170 (16%) 694(17%)
Bipolar disorder 91 (8.7%) 204 (10%) 108 (10%) 403(10%)
Adjustment disorder 181 (17%) 355 (17%) 201 (19%) 737(18%)
Borderline personality disorders 104 (10%) 190 (9%) 74 (7%) 368(9%)
Other mental disorder 40 (4%) 60 (3%) 34 (3%) 134(3%)
Drug use disorders 118 (11%) 277 (14%) 198 (18%) 593(14%)
Dementias 13 (1.2%) 12 (0.6%) 5 (0.5%) 30(1%)
Other medical condition 34 (3%) 93 (5%) 36 (3%) 163(4%)
Age in years 0.1345
mean (SD) 39.0 (15.5) 38.9 (15.0) 40.0 (15.5) 39.2(15.3)
Length of stay 0.5144
mean (SD) 16.1 (35.9) 17.6 (34.4) 16.7 (28.4) 17.0 (33.4)
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The prevalence of recorded provision of nicotine de-
pendence treatment on the discharge summary was
stable from pre- to during-intervention, but increased
significantly from during to post-intervention, with an
overall significant increase from pre- to post-
intervention (4.63% absolute increase, 99% CI: 1.13 to
8.12). As shown in Fig. 1 and Table 3, the odds of re-
corded provision of nicotine dependence treatment at
discharge increased significantly from pre- to post-
intervention (AOR = 12.36, 99% CI: 6.08 to 25.14), with
this being driven by increases from the intervention to
post-intervention period (Table 3).
Stratified results for the 100-bed (~2000 discharges
per annum) and 125-bed facility (~750 discharges per
annum) are shown in Tables 2 and 3 of the Additional
file 1. The direction and strength of the associations in
the two facilities was largely similar to the overall aggre-
gated findings. However, due to the lower number of an-
nual admissions in the 125-bed facility, the number of
events was small and power was reduced, resulting in
wide confidence intervals around the estimates for this
facility (see Additional file 1: Table 3).
Discussion
This is the first study to examine the effectiveness of a
clinical practice change intervention in increasing the re-
corded provision of nicotine dependence treatment in
inpatient psychiatric facilities. The findings suggest that
the intervention was effective in increasing clinician-
recorded provision of nicotine dependence treatment,
with increases identified for all five nicotine dependence
treatment measures during the intervention period, and
continuing for up to five months post-intervention.
The magnitude of the observed improvement in re-
cording of nicotine dependence treatment in our study
are similar to [18], and in some cases greater than [37]
those reported in previous studies conducted in general
hospital facilities. For example, a four-year interrupted
time series study utilising a similar multi-component
clinical practice change intervention in 37 general public
hospitals in Australia [38] found significant increases in
recorded provision of nicotine dependence treatment
from pre to post-intervention, including: advice to quit
(8.6% increase vs. 8% in our study); and provision of in-
patient NRT (16% vs. 18%) [38]. Similarly a controlled
study conducted across four hospitals in the same state
as the current study identified increases in nicotine de-
pendence treatment that ranged from 9 to 22% [39]. It is
particularly encouraging that in the present study, the
increases in nicotine dependence treatment occurred in
inpatient psychiatric settings—settings known to have
higher rates of patient smoking [10], and negative staff
attitudes to delivering smoking treatment [40].
The observed rates of recorded provision of the five
nicotine dependence treatment variables were stable
across the pre-intervention period, and increased in
Fig. 1 The proportions (yes) of each of the five nicotine dependence treatment outcomes, plotted fortnightly for the total patient sample at pre-
(1st June-31st October, 2009, n = 1054), during (1st November 2009–31st July 2010, n = 2043) and post-intervention (1st August-31st December
2010, n = 1078)
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accordance with the timing of the delivery of the clinical
practice change intervention. Critically, these increases
continued into the post-intervention period, suggesting
not only the efficacy of the clinical practice change inter-
vention, but some degree of sustainability of effect. This
finding adds to the growing body of evidence that multi-
modal nicotine dependence treatment interventions
show efficacy in increasing nicotine dependence treat-
ment provision in hospital settings both during, and
after implementation of the intervention [38]. Further,
the observed increases across multiple elements of nico-
tine dependence treatment are noteworthy, as previous
studies have indicated improvements in some but not all
forms of treatment assessed [27, 38]. This finding is par-
ticularly important, as there is evidence that patient re-
ceipt of multiple elements of such treatment increases
the likelihood of stopping smoking [13, 41, 42]. It is
possible that the lower baseline proportions of patients
receiving nicotine dependence treatment in our study
(e.g. 0.85% for quit advice) compared to general medical
settings (e.g. 5.4% for quit advice in Slattery et al.’s [38]
study), paired with the higher rates of smoking and nico-
tine dependence in these samples relative to the general
population [3, 10] meant that there was greater scope
for improvement to be made and detected across all
nicotine dependence outcomes in the current study. Fur-
ther, there are inherent differences across studies in
intervention length, intensity, follow-up length and
outcome measurement that may have differentially influ-
enced the results across these studies, the degree to
which is unknown.
Notwithstanding the consistent increases in all out-
comes, at post-intervention, an assessment of smoking
status occurred for only 52% of patients, with even lower
rates for other elements of nicotine dependence treat-
ment. This suggests that additional strategies may be re-
quired to ensure that all patients receive nicotine
dependence treatment. Previous research has indicated
that interventions that are integrated with, and address
existing hospital systems and procedures may maximise
nicotine dependence treatment delivery [13, 32, 39, 43].
For example, enhancing hospital accountability by in-
cluding nicotine dependence treatment indicators in
hospital accreditation and performance processes has
been suggested to increase the provision of such care
[44, 45]. Similarly, incorporating nicotine dependence
treatment within existing hospital computer systems
(such as an electronic medical record system) has been
shown to increase smoking care, and may also reduce
clinician time burden [32]. The improved, but still sub-
optimal rates of smoking status assessment and nicotine
dependence treatment at post-intervention in this study
may have been due to the absence of such strategies in
the intervention, and/or the length of the intervention
period. Little research has investigated the intervention
strategy intensity or duration required for successful
guideline implementation and clinical practice change
[19, 20]. Similarly, due to the complex, multi-modal and
interrelated nature of the intervention components used
in the current study, we are unable to comment on which
single component—or combinations of components—had
the greatest effect, which may be important for implemen-
tation in clinical settings where resources may be limited.
Future researchers in this area may consider examining
the effect of individual intervention components and col-
lecting data regarding intervention implementation costs,
in order to advise cost-effectiveness analyses.
This study has multiple strengths, including its’ large
sample size, inclusion of a number of patient diagnostic
groups, and use of systematically independently col-
lected medical record audit data. However, a number of
study characteristics may have impacted on its findings.
Firstly, we relied on medical record audit as a measure
of clinical staff provision of nicotine dependence treat-
ment. It is possible that clinical staff may have recorded
care delivery in the absence of it occurring, and hence
overestimated actual delivery of nicotine dependence
treatment. However, systematic review evidence suggests
that medical record audit is more likely to underestimate
clinical staff behaviour [46]. Although the audit staff
were non-clinical health service staff who were inde-
pendent of the research team and were not privy to the
intervention activities, they may have become aware of
the intervention process via being part of the broader
health system. Thus we cannot exclude the possibility
that the audit staff may have recorded data more
rigorously in the post-intervention period than before.
Further, although the hospital nicotine dependence treat-
ment guidelines recommend a clear ‘pathway’ of care
(see Additional file 1) where smoking status is assessed,
brief advice is provided, NRT is prescribed and patients
are monitored until discharge, it is unclear from the
audit data to what extent clinical staff followed this
pathway in a linear matter. For example, NRT may have
been provided before (or in the absence of) provision of
brief advice to quit, particularly so for patients who may
be well known to clinical staff due to repeat admissions.
While it is out of scope here to comment on each indi-
vidual patient’s nicotine dependence treatment pathway,
future studies in this area may aim to examine both glo-
bal increases care delivery (as demonstrated here), but
also improvements in adherence to the care pathway as
detailed in clinical practice guidelines.
Secondly, given that the recording of smoking status
did not occur systematically for all patients at any time
point during the study, the true sample of smokers for
whom nicotine dependence treatment should be deliv-
ered was unknown. Previous research conducted among
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patients in the same facility within the same timeframe
indicated that smoking rates were approximately 53%
[47, 48]. Hence, the rates of nicotine dependence treat-
ment presented here are likely to underestimate the true
proportion of smokers receiving nicotine dependence
treatment. Nevertheless, assuming that the prevalence of
smoking status remained stable across the study period
[32, 33], the observed increases in nicotine dependence
treatment provision over time are considered to likely
reflect an increase in nicotine dependence treatment de-
livery to patients who are smokers.
Third, given our focus on increasing clinician-
recorded nicotine dependence treatment according to
the standard hospital care guidelines, we did not collect
data on other factors that may have had an impact on
the likelihood of clinical staff providing and recording
such treatment to patients. This may have included the
voluntary or involuntary status of patients, which has
shown to be important in the implementation of smoke-
free policies in locked psychiatric facilities, given the
relative abilities of these patients to leave the grounds to
smoke. While we did not collect such data in our study,
in Australia in 2014–15 it was estimated that 31.1% of
all hospitalisations to specialised psychiatric care services
were for patients who had an involuntary admission
[49]. These two groups may represent distinct clinical
cohorts for whom there may have been a differential ef-
fect of the intervention [50]. We also did not collect data
regarding patient use of other pharmacological treat-
ments for smoking cessation outside of those provided
as part of standard hospital care guidelines, including
varenicline and bupropion (which were not available
through the hospital pharmacy) or oral or nasal nicotine
spray (which was not approved for use in Australia at
the time of the study). The use of such other pharmaco-
therapies outside of those provided as standard hospital
care may have influenced the likelihood of clinicians
providing routine hospital nicotine dependence treat-
ment to patients.
Further, utilising a controlled trial design was not feas-
ible, and the use of a non-controlled design constrains
our ability to directly attribute the observed increases in
recording of nicotine dependence treatment to the inter-
vention component. Given the limited resources avail-
able, the study facilities were required to be within close
geographical proximity to the administering University,
and were too dissimilar in size and annual patient ad-
missions in order for one site to act as a comparator to
the other. As such, the interrupted time series design
was adopted, as it has been demonstrated to be appro-
priate in evaluating the efficacy of clinical practice
change interventions in hospital settings where whole-
of-system practice change is the focus of the interven-
tion [38]. Further, this pragmatic study design provides
one means of accelerating the research translation
process by simultaneously disseminating the interven-
tion strategy whilst conducting the evaluation [51].
Where feasible, future researchers aiming to examine
the efficacy of a clinical practice change intervention
should consider the inclusion of a comparison condition,
such as through the use of a randomised controlled trial
design (e.g. [52]) or through hybrid evaluation designs,
such multiple baseline (e.g. [53]) or stepped wedge clus-
ter randomised designs [51].
Finally, although the study data were collected from
2009–2010, more recent evaluations of the study
facilities by the authorship team indicate that prevalence
of smoking among patients, and clinician provision of
nicotine dependence treatment (including both patient
report and medical record audit) are unlikely to have
changed in this time [34, 47, 54]. Given that this study is
the first to examine the efficacy of a clinical practice
change intervention in increasing nicotine dependence
treatment to smokers within inpatient psychiatric facil-
ities, it provides a strong basis for future studies further
develop the intervention design and outcome measures,
and to explore potential differential effects of the inter-
vention among specific subgroups of the patient popula-
tion, including those with voluntary/involuntary
admission status, and those who may be using other
pharmacotherapies, such as varenicline and bupropion.
Conclusions
This study is the first to examine the effectiveness of a
multi-modal clinical practice change intervention in
increasing recorded nicotine dependence treatment in in-
patient psychiatric facilities. The use of inpatient psychi-
atric facilities as a setting for supporting and encouraging
smokers to change behaviour may make an important
contribution to addressing the recognised need to reduce
smoking rates for this population group. Our results pro-
vide evidence that improvement in the routine recording
of nicotine dependence treatment is achievable on a
whole-of hospital basis and are sustainable in the short to
medium term. However additional strategies are required
to ensure all smokers are systematically identified and of-
fered nicotine dependence treatment.
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